Steward Partners Investment Advisory
PPH icon

Steward Partners Investment Advisory’s VanEck Pharmaceutical ETF PPH Stock Holding History

Steward Partners Investment Advisory’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149K Sell
1,364
-109
-7% -$11.3K ﹤0.01% 2389
2026
Q1 		$153K Hold
1,473
– – ﹤0.01% 2152
2025
Q4 		$152K Sell
1,473
-15,500
-91% -$1.51M ﹤0.01% 2076
2025
Q3 		$1.53M Buy
16,973
+812
+5% +$71.1K 0.01% 875
2025
Q2 		$1.42M Hold
16,161
– – 0.01% 838
2025
Q1 		$1.47M Sell
16,161
-5,577
-26% -$502K 0.01% 774
2024
Q4 		$1.88M Buy
21,738
+14,908
+218% +$1.35M 0.02% 663
2024
Q3 		$649K Buy
6,830
+504
+8% +$47.9K 0.01% 1009
2024
Q2 		$579K Sell
6,326
-145
-2% -$12.9K 0.01% 1002
2024
Q1 		$587K Sell
6,471
-825
-11% -$72.2K 0.01% 991
2023
Q4 		$594K Buy
7,296
+185
+3% +$14.5K 0.01% 923
2023
Q3 		$568K Sell
7,111
-2,006
-22% -$162K 0.01% 876
2023
Q2 		$718K Buy
9,117
+9,037
+11,296% +$707K 0.01% 806
2023
Q1 		$6.21K Hold
80
– – ﹤0.01% 2711
2022
Q4 		$6.22K Hold
80
– – ﹤0.01% 2690
2022
Q3 		$5K Hold
80
– – ﹤0.01% 2778
2022
Q2 		$6K Hold
80
– – ﹤0.01% 2710
2022
Q1 		$6K Hold
80
– – ﹤0.01% 2842
2021
Q4 		$6K Hold
80
– – ﹤0.01% 2778
2021
Q3 		$6K Hold
80
– – ﹤0.01% 2764
2021
Q2 		$6K Hold
80
– – ﹤0.01% 6441
2021
Q1 		$5.52K Hold
80
– – ﹤0.01% 2988
2020
Q4 		$5K Hold
80
– – ﹤0.01% 2525
2020
Q3 		$5K Buy
+80
New +$5.06K ﹤0.01% 2380

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Steward Partners Investment Advisory's PPH Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its VanEck Pharmaceutical ETF (PPH) stake by 7.4% in Q2 2026, selling an estimated $11.3K and leaving 1,364 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #2389.

Steward Partners Investment Advisory first reported a position in PPH in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.88M in Q4 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Steward Partners Investment Advisory held 1,364 shares of VanEck Pharmaceutical ETF worth $149K as of Q2 2026.
  • Steward Partners Investment Advisory sold 109 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $11.3K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2389 holding.
  • Steward Partners Investment Advisory first reported a position in VanEck Pharmaceutical ETF in Q3 2020 and has held it in 24 quarters since.
  • Steward Partners Investment Advisory's VanEck Pharmaceutical ETF position peaked at $1.88M in Q4 2024.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.